(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.39% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.42%.
Neogen's revenue in 2026 is $870,400,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $196,433,581,453, with the lowest NEOG revenue forecast at $188,457,092,388, and the highest NEOG revenue forecast at $202,606,747,266. On average, 7 Wall Street analysts forecast NEOG's revenue for 2028 to be $192,536,920,448, with the lowest NEOG revenue forecast at $175,764,051,697, and the highest NEOG revenue forecast at $208,062,508,787.
In 2029, NEOG is forecast to generate $179,957,268,884 in revenue, with the lowest revenue forecast at $172,900,976,207 and the highest revenue forecast at $185,251,668,953.